Shalby zooms 10% ahead of meeting with Swiss investor: Stake deal on the cards?

Shalby Hospitals

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Shares of Shalby Ltd rallied over 10 percent on October 11, ahead of the company's meeting with Swiss healthcare investor HBM Partners on October 17.

The chatter on dealer circles is that a stake buy could be on the cards. However, Shalby in an exchange filing on October 9 had said, "No unpublished price-sensitive information pertaining to the company will be shared at this meeting."

Promoter and promoter group hold 74.12 percent stake in Shalby.

HBM Partners, founded in 2001, has about $2 billion in assets under management with investments in companies like 1mg, Antiva Biosciences, and Werewolf Therapeutics.

Follow our live blog for all the market action

At 12pm, the Shalby stock was quoting Rs 260.20 on the NSE, up by 7.81 percent from its previous close. The average trading volumes of 21 lakh was over five times the one-month average volume of 4 lakh. The stock has doubled investors' wealth since the March lows of Rs 115.

In June, the company had signed an agreement with Divine Super Specialty Hospital, in Ranchi, to set up a franchise-owned, Shalby-managed (FOSM) hospital in the region. Divine Super Specialty Hospital has a capacity of 60 beds.

Apart from capacity expansion, Shalby is also exploring opportunities in the home care sector. In an interview with CNBC-TV18 earlier this year, Shanay Shah, director of Shalby, had said: "It is not only about the revenues generated in the homecare business, but it is also about the brand loyalty that comes in."

Founded by Vikram Shah, Shalby is one of the biggest corporate hospital groups in western and central India and claims to be the largest joint replacement centre in the world, having done over 150,000 successful surgeries till date. Arthroplasty currently contributes 45 percent to the revenue mix.

About 7,695 patients were served by Shalby in Q1 FY24 as against 5,868 a year back, marking a growth of 31 percent. Average revenue per occupied bed stood at Rs 38,000 for the quarter, up 9 percent on-quarter and 8 percent on-year.